Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD) – Africa News Wire
za.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from za.com Daily Mail and Mail on Sunday newspapers.
Related Keywords